0.06
Finanzdaten der Hepion Pharmaceuticals Inc-Aktie (HEPA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 |
| Periodenlänge | 3 Monate |
| Revenues | |
|
|
|
| Interest Income/Expense | |
| Operating Income/Loss | |
| Income/Loss From Continuing Operations Before Tax | |
| Income Tax Expense/Benefit | |
| Income/Loss From Continuing Operations After Tax | |
|
|
|
| Preferred Stock Dividends And Other Adjustments | |
| Attributable To Noncontrolling Interest | |
| Basic Average Shares | |
| Diluted Average Shares | |
| Basic Earnings Per Share | |
| Diluted Earnings Per Share | |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
Kapitalisierung:
|
Volumen (24h):